GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cohance Lifesciences Ltd (NSE:COHANCE) » Definitions » Total Long-Term Liabilities

Cohance Lifesciences (NSE:COHANCE) Total Long-Term Liabilities : ₹8,259 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Cohance Lifesciences Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Cohance Lifesciences's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₹8,259 Mil.

Cohance Lifesciences Total Long-Term Liabilities Historical Data

The historical data trend for Cohance Lifesciences's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cohance Lifesciences Total Long-Term Liabilities Chart

Cohance Lifesciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Long-Term Liabilities
Get a 7-Day Free Trial 739.19 921.13 717.94 965.27 8,259.20

Cohance Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 965.27 - 2,390.00 - 8,259.20

Cohance Lifesciences Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Cohance Lifesciences Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cohance Lifesciences's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cohance Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cohance Lifesciences Ltd (NSE:COHANCE) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:532296 BOM:524494 BOM:532331 BOM:540222 BOM:543635 BOM:506943 NSE:GLAND BOM:544210 BOM:532300 BOM:540596 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
543064:India
Address
Hitech City Road, Panmaktha Plot, 1, 202, 2nd Floor, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Opposite IKEA, Hyderabad, TG, IND, 500081
Website
https://www.cohance.com
Cohance Lifesciences Ltd is a CDMO and API platform, offering products and services across all phases of a molecule's lifecycle from development to commercialization. Its Business Units comprise: CDMO, API+ and Formulations, and Clinical and Analytical Services.

Cohance Lifesciences Headlines

No Headlines